Erhard Edwin Lee
Vorstandsvorsitzender bei AMG Analysen & Anlagen AG
Profil
Erhard Edwin Lee is the founder and former Chief Executive Officer of AMG Analysen & Anlagen AG, which is founded in 2001.
He currently holds the position of Director at Lipideon Biotechnology AG and Glycemicon AG.
Aktive Positionen von Erhard Edwin Lee
| Unternehmen | Position | Beginn |
|---|---|---|
AMG Analysen & Anlagen AG
 AMG Analysen & Anlagen AG Investment ManagersFinance AMG Analysen & Anlagen AG (AMG) is an independent investment management firm headquartered in Zurich, Switzerland. The firm was founded by Erhard Lee in 2001. AMG provides a range of wealth management services for private clients. | Vorstandsvorsitzender | 01.01.2001 |
Lipideon Biotechnology AG
 Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - |
Glycemicon AG
 Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
AMG Analysen & Anlagen AG
AMG Analysen & Anlagen AG Investment ManagersFinance AMG Analysen & Anlagen AG (AMG) is an independent investment management firm headquartered in Zurich, Switzerland. The firm was founded by Erhard Lee in 2001. AMG provides a range of wealth management services for private clients. | Finance |
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Commercial Services |
Glycemicon AG
Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Commercial Services |
